Figure 4.
The indicated cytotoxic drugs induce an upregulation of PD-L1 at the surface of cancer cells and/or PD-1 at the surface of CD8+ tumor-infiltrating lymphocytes (TILs). Thus, they promote tumor response to antibodies targeting PD-L1 or PD-1.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.